Parrish Jay 4
4 · Vir Biotechnology, Inc. · Filed Jan 5, 2021
Insider Transaction Report
Form 4
Parrish Jay
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-01-04$1.49/sh+6,945$10,313→ 229,167 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-01−6,945→ 16,203 totalExercise: $1.49Exp: 2027-10-05→ Common Stock (6,945 underlying) - Sale
Common Stock
2021-01-04$26.32/sh−6,945$182,795→ 222,222 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020.
- [F2]1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.